Ann Hynes
Stock Analyst at Mizuho
(5.00)
# 2
Out of 4,876 analysts
251
Total ratings
65.75%
Success rate
246.65%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $515 → $350 | $307.20 | +13.93% | 18 | May 16, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $200 → $173 | $145.18 | +19.16% | 15 | May 15, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $210 → $190 | $157.85 | +20.37% | 12 | May 15, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $37 → $32 | $21.72 | +47.33% | 11 | May 14, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $10 → $8 | $5.03 | +59.20% | 3 | May 14, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $178.18 | +6.07% | 15 | Apr 9, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $376 → $400 | $296.53 | +34.90% | 8 | Apr 9, 2025 | |
| MEDP Medpace Holdings | Maintains: Outperform | $400 → $355 | $308.79 | +14.96% | 2 | Apr 9, 2025 | |
| HUM Humana | Maintains: Outperform | $305 → $316 | $243.00 | +30.04% | 8 | Apr 9, 2025 | |
| ELV Elevance Health | Maintains: Outperform | $455 → $505 | $379.95 | +32.91% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $150.71 | +2.85% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $68.53 | +10.90% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $13.55 | +32.89% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $13.79 | +8.77% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $167.35 | -28.29% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $23.19 | -13.76% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $20.96 | +33.59% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 → $130 | $173.31 | -24.99% | 14 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $122.27 | -22.30% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $330.20 | +16.60% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $179.68 | +11.31% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.77 | +15,041.24% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $730.70 | -30.89% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $261.00 | -11.88% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $381.26 | -27.87% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $11.43 | +118.72% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $21.79 | +129.46% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $76 | $53.91 | +40.98% | 7 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.48 | +3,751.35% | 1 | Sep 21, 2017 |
UnitedHealth Group
May 16, 2025
Maintains: Outperform
Price Target: $515 → $350
Current: $307.20
Upside: +13.93%
ICON Public Limited Company
May 15, 2025
Maintains: Outperform
Price Target: $200 → $173
Current: $145.18
Upside: +19.16%
IQVIA Holdings
May 15, 2025
Maintains: Outperform
Price Target: $210 → $190
Current: $157.85
Upside: +20.37%
Acadia Healthcare Company
May 14, 2025
Maintains: Neutral
Price Target: $37 → $32
Current: $21.72
Upside: +47.33%
Fortrea Holdings
May 14, 2025
Maintains: Neutral
Price Target: $10 → $8
Current: $5.03
Upside: +59.20%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $178.18
Upside: +6.07%
Molina Healthcare
Apr 9, 2025
Maintains: Outperform
Price Target: $376 → $400
Current: $296.53
Upside: +34.90%
Medpace Holdings
Apr 9, 2025
Maintains: Outperform
Price Target: $400 → $355
Current: $308.79
Upside: +14.96%
Humana
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $243.00
Upside: +30.04%
Elevance Health
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $379.95
Upside: +32.91%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $150.71
Upside: +2.85%
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $68.53
Upside: +10.90%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $13.55
Upside: +32.89%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $13.79
Upside: +8.77%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $167.35
Upside: -28.29%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $23.19
Upside: -13.76%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $20.96
Upside: +33.59%
May 1, 2024
Reiterates: Buy
Price Target: $118 → $130
Current: $173.31
Upside: -24.99%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $122.27
Upside: -22.30%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $330.20
Upside: +16.60%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $179.68
Upside: +11.31%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.77
Upside: +15,041.24%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $730.70
Upside: -30.89%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $261.00
Upside: -11.88%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $381.26
Upside: -27.87%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $11.43
Upside: +118.72%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $21.79
Upside: +129.46%
Jul 11, 2023
Maintains: Neutral
Price Target: $80 → $76
Current: $53.91
Upside: +40.98%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.48
Upside: +3,751.35%